Impact of COVID-19 on maxillofacial surgery practice: a worldwide survey. Issue 6 (June 2020)

• Record Type: Journal Article
• Authors: Maffia, F.; Fontanari, M.; Vellone, V.; Cascone, P.; Mercuri, L.G.
• Is Part Of: International journal of oral & maxillofacial surgery. Volume 49:Issue 6(2020:Jun.)
• Page Start: 827
• Page End: 835
• Publication Date: 2020-06
• Subjects: coronavirus -- COVID-19 -- maxillofacial surgery -- pandemic -- outbreak -- DORSCON Scale; Mouth -- Surgery -- Periodicals; Maxilla -- Surgery -- Periodicals; Dentistry -- Periodicals; Dentistry, Operative; Oral Surgical Procedures; Surgery, Oral; Dentistry; Maxilla -- Surgery; Mouth -- Surgery; Electronic journals; Periodicals; 617.52059
• DOI: 10.1016/j.ijom.2020.04.015
• Languages: English
• ISSNs: 0901-5027

Abstract

Abstract: The outbreak of coronavirus disease 2019 (COVID-19) is rapidly changing our habits. To date, April 12, 2020, the virus has reached 209 nations, affecting 1.8 million people and causing more than 110, 000 deaths. Maxillofacial surgery represents an example of a specialty that has had to adapt to this outbreak, because of the subspecialties of oncology and traumatology. The aim of this study was to examine the effect of this outbreak on the specialty of maxillofacial surgery and how the current situation is being managed on a worldwide scale. To achieve this goal, the authors developed an anonymous questionnaire which was posted on the internet and also sent to maxillofacial surgeons around the globe using membership lists from various subspecialty associations. The questionnaire asked for information about the COVID-19 situation in the respondent's country and in their workplace, and what changes they were facing in their practices in light of the outbreak. The objective was not only to collect and analyse data, but also to highlight what the specialty is facing and how it is handling the situation, in the hope that this information will be useful as a reference in the future, not only for this specialty, but also for others, should COVID-19 or a similar global threat arise again.